Konidaris Tasos
SEC CIK 1320982 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| AMRX | Amneal Pharmaceuticals, Inc. | EVP, CFO | 449.4K | — | $5.55M | 17 | 2022-03-01 | 2026-03-03 |
Most active insiders at AMRX, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Shah Nikita | EVP | — | $4.14M |
| 2 | Daly Jason B. | EVP, CLO | — | $3.77M |
| 3 | Kiely John | Dir | — | $882.0K |
| 4 | Nark Ted C | Dir | — | $586.0K |
| 5 | Autor Deborah M. | Dir | — | $450.6K |
| 6 | George Jeffrey P. | Dir | — | — |
| 7 | Patel Tushar Bhikhubhai | 10% | — | — |
| 8 | Patel Chirag K. | Pres, Co-CEO, Dir | — | — |
| 9 | Patel Gautam | Dir | — | — |
| 10 | Patel Chintu | Co-CEO, Dir | — | — |
| 12 | Konidaris Tasos | EVP, CFO | — | — |
Transactions 17
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2026-03-05 | 2026-03-03+ | AMRX | Amneal Pharmaceuticals, Inc. | Konidaris Tasos | EVP, CFO | F - Tax | $13.31 | -306.6K | 449.4K | -41% | -$4.08M |
| DM | 2026-03-05 | 2026-03-03+ | AMRX | Amneal Pharmaceuticals, Inc. | Konidaris Tasos | EVP, CFO | M - OptEx | — | +633.9K | 657.3K | +2,704% | — |
| M | 2025-08-15 | 2025-08-13+ | AMRX | Amneal Pharmaceuticals, Inc. | Konidaris Tasos | EVP, CFO | S - Sale | $9.33 | -499.7K | 460.5K | -52% | -$4.66M |
| 2025-03-07 | 2025-03-05 | AMRX | Amneal Pharmaceuticals, Inc. | Konidaris Tasos | EVP, CFO | S - Sale | $8.91 | -100.0K | 621.9K | -14% | -$891.0K | |
| DM | 2025-03-05 | 2025-03-03+ | AMRX | Amneal Pharmaceuticals, Inc. | Konidaris Tasos | EVP, CFO | M - OptEx | — | +327.8K | 636.3K | +106% | — |
| DM | 2025-03-05 | 2025-03-03+ | AMRX | Amneal Pharmaceuticals, Inc. | Konidaris Tasos | EVP, CFO | F - Tax | $8.77 | -155.9K | 611.9K | -20% | -$1.37M |
| D | 2025-03-04 | 2025-03-01 | AMRX | Amneal Pharmaceuticals, Inc. | Konidaris Tasos | EVP, CFO | M - OptEx | — | +36.2K | 563.5K | +7% | — |
| D | 2025-03-04 | 2025-03-01 | AMRX | Amneal Pharmaceuticals, Inc. | Konidaris Tasos | EVP, CFO | F - Tax | $8.67 | -13.5K | 550.0K | -2% | -$117.0K |
| D | 2024-03-14 | 2024-03-12 | AMRX | Amneal Pharmaceuticals, Inc. | Konidaris Tasos | EVP, CFO | F - Tax | $5.31 | -30.8K | 527.3K | -6% | -$163.5K |
| D | 2024-03-14 | 2024-03-12 | AMRX | Amneal Pharmaceuticals, Inc. | Konidaris Tasos | EVP, CFO | M - OptEx | — | +87.7K | 558.1K | +19% | — |
| DM | 2024-03-05 | 2024-03-01+ | AMRX | Amneal Pharmaceuticals, Inc. | Konidaris Tasos | EVP, CFO | F - Tax | $5.47 | -49.3K | 433.2K | -10% | -$269.6K |
| DM | 2024-03-05 | 2024-03-01+ | AMRX | Amneal Pharmaceuticals, Inc. | Konidaris Tasos | EVP, CFO | M - OptEx | — | +138.8K | 449.1K | +45% | — |
| D | 2023-03-14 | 2023-03-12 | AMRX | Amneal Pharmaceuticals, Inc. | Konidaris Tasos | EVP, CFO | M - OptEx | — | +87.7K | 380.8K | +30% | — |
| D | 2023-03-07 | 2023-03-03 | AMRX | Amneal Pharmaceuticals, Inc. | Konidaris Tasos | EVP, CFO | M - OptEx | — | +45.3K | 293.1K | +18% | — |
| D | 2023-03-03 | 2023-03-01 | AMRX | Amneal Pharmaceuticals, Inc. | Konidaris Tasos | EVP, CFO | M - OptEx | — | +36.2K | 247.8K | +17% | — |
| D | 2022-03-15 | 2022-03-12 | AMRX | Amneal Pharmaceuticals, Inc. | Konidaris Tasos | EVP, CFO | M - OptEx | — | +87.7K | 211.6K | +71% | — |
| D | 2022-03-03 | 2022-03-01 | AMRX | Amneal Pharmaceuticals, Inc. | Konidaris Tasos | EVP, CFO | M - OptEx | — | +36.2K | 123.9K | +41% | — |
Purchase Sale Sale after option exercise All abbreviations